Ovarian cancer often goes undetected for a long time. In seven out of 10 patients, the tumor has already formed secondary ...

Ovarian cancer is one of the most common forms of cancer, a type that usually remains undiagnosed for a while in many ...

How Does Zejula Work in Advanced Ovarian Cancer? In platinum-based chemotherapy, the platinum in the medicine binds to the genetic material (DNA) of cancer cells. This damages the cancer cells and ...

Gynecological clear cell cancers (CCCs), very aggressive forms of ovarian and endometrial malignancies, respond poorly to chemotherapy. The low response rates underscore a significant clinical need to ...

Known as "the silent killer" due to its lack of symptoms and reliable screening tests, ovarian cancer remains one of the ...

Please provide your email address to receive an email when new articles are posted on . The addition of an investigational immunotherapy to chemotherapy prolonged survival for women with advanced ...

Researchers have developed a new prediction tool that could help clinicians better assess whether complete tumour removal is ...

CHICAGO -- Omitting lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy did not compromise ...

Patients with metastatic breast or advanced ovarian cancer spend about 7 hours per week on cancer-related tasks, including ...

There are currently few effective treatment options for patients with recurrent ovarian cancer and other solid tumors, but City of Hope researchers are trying to change that. Researchers with City of ...

Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...

PHILADELPHIA (CBS) -- Ovarian cancer is called the silent killer because it's hard to diagnose and treat, but that's slowly changing. "This garden is my happy place It feeds my heart and my soul," ...